Skip to main content
< Back
About
About the conference
Organisers & Partners
Registration
App
Podcast
Early Career Researchers
Call for abstracts
Guidelines
Latest updates
Press room
Venue
Programme
Full programme
Programme outline
Tracks
Speakers
All speakers
Keynote speakers
Side events
Subscribe
Programme
Keywords
Africa
Alcohol
Asia
Basic research
Behavioural addictions
Cannabis
Capacity-building
Civil society
Clinical research/practice
Comorbidity
COVID-19
Criminal justice/prisons
Criminology
Drug user's perspectives
E-health/digitalisation
ECR (Early Career Researchers)
Europe
Gender perspectives
Harm reduction
Health inequalities
Hepatitis
HIV
Infectious diseases
Markets
Mental health and wellbeing
Monitoring and evaluation
Neuroscience
New psychoactive substances
Nicotine/tobacco
North America
Oceania
Opiates
Overdose
Policy
Prescription drugs
Prevention
Psychostimulants
Public health
Qualitative methods
Quantitative methods
Recreational setting
Risky behaviours
South America
Toxicology and forensic analysis
Treatment
Underrepresented groups
Workforce
Youth/children
- Any -
WED
23 OCT
THU
24 OCT
FRI
25 OCT
All
Plenary session
Big debate
Major session
Workshop
Oral presentation session
Short communication session
e-short communication session
e-poster session
Video contest
PDF version
Wed 23 Oct
10:00
e-poster session day 1
10:00
to
19:20
Digital kiosks
e-poster session
e-poster session day 1
10:00
to
19:20
Digital kiosks
e-poster session
e-poster session day 1
10:00
to
19:20
Digital kiosks
e-poster session
11:50
Mechanisms and outcomes in substance use prevention among youth
11:50
to
13:20
Room 5A
Oral presentation session
Gambling: work-related, financial, and criminological issues
11:50
to
13:20
Room 5B
Oral presentation session
14:20
Neuroscience and cognition
14:20
to
15:50
Auditorium III
Short communication session
Tobacco, mental health and other substance use
14:20
to
15:50
Auditorium VII
Oral presentation session
Neurocognitive processes in behavioural addictions
14:20
to
15:50
Room 5B
Oral presentation session
Challenge of measuring use and impact of cannabinoids
14:20
to
15:50
Room 1.07
Oral presentation session
16:00
Substance use and psychosis
16:00
to
17:30
Auditorium VII
Oral presentation session
Surveillance of drug-related morbidity and mortality
16:00
to
17:30
Room 5A
Oral presentation session
Assessment of behavioural addictions
16:00
to
17:30
Room 5B
Oral presentation session
Responses to behavioural addictions
16:00
to
17:30
Room 1.05
Short communication session
Problematic gambling and gaming
16:00
to
17:30
Room 1.07
Short communication session
17:50
Drug use trends
17:50
to
19:20
Auditorium IV
Oral presentation session
Novel and contextual approaches in prevention
17:50
to
19:20
Room 5A
Oral presentation session
Opioids: trends, use and treatments
17:50
to
19:20
Room 1.06
Short communication session
Professionals' insights into the use of AI and digital tools in addictions'
17:50
to
19:20
Room 1.15
Workshop
Thu 24 Oct
11:50
Opioid Agonist Treatment: novel formulations and challenges
11:50
to
13:20
Auditorium IV
Oral presentation session
Emerging drug harms, DCRs and other responses
11:50
to
13:20
Auditorium VII
Short communication session
The challenges of the digital era: an interdisciplinary investigation of screen time and social media
11:50
to
13:20
Auditorium VIII
Major session
14:20
New opportunities for informing clinical practice and policy development in the area of behavioural addictions
14:20
to
15:50
Auditorium I
Major session
Novel neurobiology - cannabis, cognition and craving
14:20
to
15:50
Auditorium III
Oral presentation session
Novel neurobiology - cannabis, cognition and craving
14:20
to
15:50
Auditorium III
Oral presentation session
Understanding drug-related deaths
14:20
to
15:50
Auditorium IV
Oral presentation session
Conceptual frameworks for studying drug policy
14:20
to
15:50
Auditorium VI
Oral presentation session
16:00
Cannabis legalisation — models and impacts
16:00
to
17:30
Auditorium VI
Oral presentation session
Cannabis legalisation — models and impacts
16:00
to
17:30
Auditorium VI
Oral presentation session
Policy issues in gambling
16:00
to
17:30
Room 5B
Oral presentation session
17:50
Misuse of medicines
17:50
to
19:20
Auditorium VIII
Oral presentation session
Behavioural addictions, prevention and theory
17:50
to
19:20
Room 1.05
Short communication session
Internet, smartphones and social media use
17:50
to
19:20
Room 1.07
Short communication session
Fri 25 Oct
11:50
Gaming and social media use
11:50
to
13:20
Auditorium III
Oral presentation session
Intentional and non-intentional drug-related deaths
11:50
to
13:20
Auditorium IV
Oral presentation session
Psychedelics 2
11:50
to
13:20
Auditorium VI
Oral presentation session
Emerging challenges in drug markets: monitoring, measurement & impacts
11:50
to
13:20
Room 1.05
Short communication session
Emerging challenges in drug markets: monitoring, measurement & impacts
11:50
to
13:20
Room 1.05
Short communication session
Gaming and health
11:50
to
13:20
Room 1.06
Short communication session
How can cannabis policy goals inform the development of evaluation indicators?
11:50
to
13:20
Room 1.08
Workshop
14:20
Findings from The Lancet Public Health Commission on Gambling: protecting the public from gambling harms
14:20
to
15:50
Auditorium I
Oral presentation session
Young people and drugs
14:20
to
15:50
Auditorium III
Oral presentation session
Young people and drugs
14:20
to
15:50
Auditorium III
Oral presentation session
Holistic care for mental well-being
14:20
to
15:50
Room 1.05
Short communication session
Holistic care for mental well-being
14:20
to
15:50
Room 1.05
Short communication session
MENU
Back
www.lisbonaddictions.eu
My profile
Notifications
My favourites
Scan contacts
My contacts
Settings